-Avadel Pharmaceuticals Announces Interim Data from the Open-Label RESTORE Study at the 2022 American Academy of Neurology Annual Meeting

Media coverage

• Title	-Avadel Pharmaceuticals Announces Interim Data from the Open-Label RESTORE Study at the 2022 American Academy of Neurology Annual Meeting
  Media name/outlet	M2 PressWIRE
  Country/Territory	United States
  Date	4/26/22
  Persons	Asim Roy

• Title	-Avadel Pharmaceuticals Announces Interim Data from the Open-Label RESTORE Study at the 2022 American Academy of Neurology Annual Meeting
  Media name/outlet	ENP Newswire
  Country/Territory	United Kingdom
  Date	4/26/22
  Persons	Asim Roy